Monday, October 10, 2016

Eurax



crotamiton

Dosage Form: lotion and cream
Eurax® (crotamiton USP)

Lotion/Cream (10% w/w)

FOR TOPICAL USE ONLY

NOT FOR OPHTHALMIC, ORAL, OR INTRAVAGINAL USE

Rx only

Eurax Description


Eurax (crotamiton USP) is a scabicidal and antipruritic agent available as a cream or lotion for topical use only. Eurax provides 10% (w/w) of the synthetic, crotamiton USP, in a vanishing-cream or emollient-lotion base containing: carbomer-934, cetyl alcohol, diazolidinylurea, dimethicone, fragrance, laureth-23, magnesium aluminum silicate, magnesium nitrate, methylchloroisothiazolinone, methylisothiazolinone, petrolatum, propylene glycol, sodium hydroxide, steareth-2, and water. In addition, the cream contains glyceryl stearate.


Crotamiton is N-ethyl-N-(o-methylphenyl)-2-butenamide and its structural formula is:



Crotamiton USP is a colorless to slightly yellowish oil, having a faint amine-like odor. It is miscible with alcohol and with methanol. Crotamiton is a mixture of the cis and trans isomers. Its molecular weight is 203.28.



Eurax - Clinical Pharmacology


Eurax has scabicidal and antipruritic actions. The mechanisms of these actions are not known. The pharmacokinetics of crotamiton and its degree of systemic absorption following topical application have not been determined.



Indications and Usage for Eurax


For eradication of scabies (Sarcoptes scabiei) and for symptomatic treatment of pruritic skin.



Contraindications


Eurax should not be applied topically to patients who develop a sensitivity or are allergic to it or who manifest a primary irritation response to topical medications.



Warnings


If severe irritation or sensitization develops, treatment with this product should be discontinued and appropriate therapy instituted.



Precautions



General


Eurax should not be applied in the eyes or mouth because it may cause irritation. It should not be applied to acutely inflamed skin or raw or weeping surfaces until the acute inflammation has subsided.



Information for Patients


See DIRECTIONS FOR PATIENTS WITH SCABIES



Drug Interactions


None known.



Carcinogenesis and Mutagenesis and Impairment of Fertility


Long-term carcinogenicity studies in animals have not been conducted.



Pregnancy (Category C)


Animal reproduction studies have not been conducted with Eurax. It is also not known whether Eurax can cause fetal harm when applied topically to a pregnant woman or can affect reproduction capacity. Eurax should be given to a pregnant woman only if clearly needed.



Pediatric Use


Safety and effectiveness in pediatric patients have not been established.



Geriatric Use


Clinical studies with Eurax (crotamiton USP) Lotion/Cream did not include sufficient numbers of subjects aged 65 years and older to determine whether they respond differently than younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.



Adverse Reactions


Primary irritation reactions, such as dermatitis, pruritus, and rash, and allergic sensitivity reactions have been reported in a few patients.



Overdosage


There is no specific information on the effect of overtreatment with repeated topical applications in humans. A death was reported but cause was not confirmed.


Accidental oral ingestion may be accompanied by burning sensation in the mouth, irritation of the buccal, esophageal and gastric mucosa, nausea, vomiting, abdominal pain.


If accidental ingestion occurs, call your Poison Control Center.



Eurax Dosage and Administration


In Scabies: Thoroughly massage into the skin of the whole body from the chin down, paying particular attention to all folds and creases. A second application is advisable 24 hours later. Clothing and bed linen should be changed the next morning. A cleansing bath should be taken 48 hours after the last application.


In Pruritus: Massage gently into affected areas until medication is completely absorbed. Repeat as needed.


LOTION: Shake well before using.



DIRECTIONS FOR PATIENTS WITH SCABIES:


  1. Take a routine bath or shower. Thoroughly massage Eurax cream or lotion into the skin from the chin to the toes including folds and creases.

  2. Put Eurax cream or lotion under fingernails after trimming the fingernails short, because scabies are very likely to remain there. A toothbrush can be used to apply the Eurax cream or lotion under the fingernails. Immediately after use, the toothbrush should be wrapped in paper and thrown away. Use of the same brush in the mouth could lead to poisoning.

  3. A second application is advisable 24 hours later.

  4. A 60 gram tube or bottle is sufficient for two applications.

  5. Clothing and bed linen should be changed the next day. Contaminated clothing and bed linen may be dry-cleaned, or washed in the hot cycle of the washing machine.

  6. A cleansing bath should be taken 48 hours after the last application


How is Eurax Supplied


Eurax® (crotamiton USP)


Cream: 60 g tubes NDC 10631-091-60 (NSN 6505-00-116-0200)


Lotion: 60 g (2 oz.) bottles NDC 10631-092-60 (NSN 6505-01-153-4423)


454 g (16 oz.) bottles NDC 10631-092-16


SHAKE WELL before using.


Store at room temperature.


Keep out of reach of children.


RANBAXY


Jacksonville, FL 32257 USA


July 2009



PACKAGE LABEL PRINCIPAL DISPLAY PANEL



Eurax Cream


Eurax Cream 60 g Tube



Eurax Cream 60 g Carton




Eurax Lotion


Eurax Lotion 60 g (2 oz.) label



Eurax Lotion 60 g (2 oz.) Carton



Eurax 454 g (16 oz.) ECL Label (Back)



Eurax 454 g (16oz) ECL Label (Front)










Eurax  LOTION AND CREAM
Eurax  cream










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)10631-091
Route of AdministrationTOPICALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CROTAMITON (CROTAMITON)CROTAMITON100 mg  in 1 g






















Inactive Ingredients
Ingredient NameStrength
CETYL ALCOHOL 
DIAZOLIDINYLUREA 
DIMETHICONE 
MAGNESIUM ALUMINUM SILICATE 
METHYLISOTHIAZOLINONE 
PETROLATUM 
PROPYLENE GLYCOL 
SODIUM HYDROXIDE 
WATER 


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
110631-091-6060 g In 1 TUBENone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA00692712/15/2008







Eurax  LOTION AND CREAM
Eurax  lotion










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)10631-092
Route of AdministrationTOPICALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CROTAMITON (CROTAMITON)CROTAMITON100 mg  in 1 g






















Inactive Ingredients
Ingredient NameStrength
CETYL ALCOHOL 
DIAZOLIDINYLUREA 
DIMETHICONE 
MAGNESIUM ALUMINUM SILICATE 
METHYLISOTHIAZOLINONE 
PETROLATUM 
PROPYLENE GLYCOL 
SODIUM HYDROXIDE 
WATER 


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      














Packaging
#NDCPackage DescriptionMultilevel Packaging
110631-092-6060 g In 1 BOTTLENone
210631-092-16454 g In 1 BOTTLENone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA00911211/13/2008


Labeler - Ranbaxy Laboratories Inc. (169932519)

Registrant - Ranbaxy Laboratories Inc. (169932519)









Establishment
NameAddressID/FEIOperations
Contract Pharmaceuticals Limited248761249manufacture
Revised: 10/2009Ranbaxy Laboratories Inc.

More Eurax resources


  • Eurax Side Effects (in more detail)
  • Eurax Use in Pregnancy & Breastfeeding
  • Eurax Support Group
  • 0 Reviews for Eurax - Add your own review/rating


  • Eurax Monograph (AHFS DI)

  • Eurax Topical Advanced Consumer (Micromedex) - Includes Dosage Information

  • Eurax Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • Eurax Consumer Overview



Compare Eurax with other medications


  • Pruritus
  • Scabies


No comments:

Post a Comment